2LSI

Solution structure of polymerase-interacting domain of human Rev1 in complex with translesional synthesis polymerase kappa

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D 1H-13C NOESY aromatic	0.8mM [U-99% 13C; U-99% 15N] entity-1, 50mM Bis-Tris-2, 100 mM NaCl-3, 1mM DTT-4	90% H2O/10% D2O	0.1	6.5	ambient	298
2	3D 1H-13C NOESY aliphatic	0.8mM [U-99% 13C; U-99% 15N] entity-1, 50mM Bis-Tris-2, 100 mM NaCl-3, 1mM DTT-4	90% H2O/10% D2O	0.1	6.5	ambient	298
3	3D 1H-15N NOESY	0.8mM [U-99% 13C; U-99% 15N] entity-1, 50mM Bis-Tris-2, 100 mM NaCl-3, 1mM DTT-4	90% H2O/10% D2O	0.1	6.5	ambient	298
4	3D HCCH-TOCSY	0.8mM [U-99% 13C; U-99% 15N] entity-1, 50mM Bis-Tris-2, 100 mM NaCl-3, 1mM DTT-4	90% H2O/10% D2O	0.1	6.5	ambient	298
5	3D H(CCO)NH	0.8mM [U-99% 13C; U-99% 15N] entity-1, 50mM Bis-Tris-2, 100 mM NaCl-3, 1mM DTT-4	90% H2O/10% D2O	0.1	6.5	ambient	298
6	3D CBCA(CO)NH	0.8mM [U-99% 13C; U-99% 15N] entity-1, 50mM Bis-Tris-2, 100 mM NaCl-3, 1mM DTT-4	90% H2O/10% D2O	0.1	6.5	ambient	298
7	3D HNCACB	0.8mM [U-99% 13C; U-99% 15N] entity-1, 50mM Bis-Tris-2, 100 mM NaCl-3, 1mM DTT-4	90% H2O/10% D2O	0.1	6.5	ambient	298
8	3D HNCO	0.8mM [U-99% 13C; U-99% 15N] entity-1, 50mM Bis-Tris-2, 100 mM NaCl-3, 1mM DTT-4	90% H2O/10% D2O	0.1	6.5	ambient	298
9	3D HBHA(CO)NH	0.8mM [U-99% 13C; U-99% 15N] entity-1, 50mM Bis-Tris-2, 100 mM NaCl-3, 1mM DTT-4	90% H2O/10% D2O	0.1	6.5	ambient	298
10	3D HCCH-COSY	0.8mM [U-99% 13C; U-99% 15N] entity-1, 50mM Bis-Tris-2, 100 mM NaCl-3, 1mM DTT-4	90% H2O/10% D2O	0.1	6.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	800
2	Bruker	AVANCE	900

NMR Refinement
Method	Details	Software
simulated annealing, explicit water refinement		NMRPipe

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	15
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	data analysis	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	refinement	Xplor

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.